Cargando…
PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β
The development of targeted tyrosine kinase inhibitors (TKIs) has succeeded in altering the course of chronic myeloid leukemia (CML). However, a number of patients have failed to respond or experienced disease relapse following TKI treatment. Proviral integration site for moloney murine leukemia vir...
Autores principales: | Fan, Rui-Fang, Lu, Ying, Fang, Zhi-Gang, Guo, Xiao-Yan, Chen, Yu-Xin, Xu, Yi-Chuan, Lei, Ya-Mei, Liu, Ke-Fang, Lin, Dong-Jun, Liu, Ling-Ling, Liu, Xiang-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647015/ https://www.ncbi.nlm.nih.gov/pubmed/28849186 http://dx.doi.org/10.3892/mmr.2017.7215 |
Ejemplares similares
-
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
Activation of GABA(B) receptors inhibits protein kinase B /Glycogen Synthase Kinase 3 signaling
por: Lu, Frances Fangjia, et al.
Publicado: (2012) -
Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities
por: Sawaguchi, Yuichi, et al.
Publicado: (2021) -
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells
por: Bhanot, Haymanti, et al.
Publicado: (2015) -
Lithium Chloride Promotes Apoptosis in Human Leukemia NB4 Cells by Inhibiting Glycogen Synthase Kinase-3 Beta
por: Li, Liu, et al.
Publicado: (2015)